Propylthiouracil

Product NDC
67253-651
11-digit product format
672530651
Labeler code
67253
Product ID
67253-651_99a1da9d-39dd-4fc1-8470-c486e5c8b850
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Propylthiouracil
Dosage form
TABLET
Route
ORAL
Labeler
Endo USA, Inc.
Application
NDA006188
Marketing category
NDA
Marketing start
1947-07-28
Substance
PROPYLTHIOURACIL
Active strength
50 mg/1
Pharmacologic classes
Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N006188-001PROPYLTHIOURACILPROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N006188-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N006188-001PROPYLTHIOURACIL50MGTABLET / ORALABRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N006188-001PROPYLTHIOURACIL50MGTABLET / ORALBDRLD, RS, Approved before 1982e64feba35796…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07N006188-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N006188-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N006188-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N006188-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N006188-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N006188-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N006188-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N006188-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N006188-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N006188-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N006188-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N006188-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N006188-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N006188-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N006188-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N006188-001BD15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N006188-001BD15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N006188-001BD14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N006188-001BD174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N006188-001BD1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N006188-001BD1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N006188-001BD187673890dc5c…
2021-03-12 10:30 UTC2021-03N006188-001BD15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N006188-001BD18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N006188-001BD1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N006188-001BD13f01610625f2…
2019-09-15 20:21 UTC2019-09N006188-001BD1b00525d2431f…
2019-07-19 19:46 UTC2019-07N006188-001BD1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N006188-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N006188-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N006188-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N006188-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N006188-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N006188-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N006188-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05N006188-001BD1053a50430f4f…
2023-01-26 05:58 UTC2023-01N006188-001BD13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N006188-001BD13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N006188-001BD1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N006188-001BD1e64feba35796…

Additional Listing Data#

Finished product
Yes
Brand name base
Propylthiouracil
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PROPYLTHIOURACIL50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
721M9407IYInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
198175Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5199f153-e97c-2898-8204-85c73892d5a5Product name220240513

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67253-651-10Propylthiouracil100 in 1 BOTTLETABLET10017
67253-651-11Propylthiouracil1000 in 1 BOTTLETABLET100017

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
67253-651-10EA - Each67253-6516d895d06-09a1-46ca-af5f-f5f7f9475bde12014-05-02
67253-651-11EA - Each67253-651be06e68e-2120-4a94-b48c-fe3f41c8faec12014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PROPYLTHIOURACILACTIVE INGREDIENT721M9407IYPROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
PROPYLTHIOURACILACTIVE MOIETY721M9407IYPROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA0PROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUPROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
SODIUM GLYCOLATEINACTIVE INGREDIENTB75E535IMIPROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPROPYLTHIOURACIL TABLET [DAVA PHARMACEUTICALS, INC.]7
PROPYLTHIOURACILACTIVE INGREDIENT721M9407IYPROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
PROPYLTHIOURACILACTIVE MOIETY721M9407IYPROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA0PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUPROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
SODIUM GLYCOLATEINACTIVE INGREDIENTB75E535IMIPROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67253-651PROPYLTHIOURACIL TABLET [ENDO USA, INC.]17Current NDC, Legacy NDC, 2 package rows20250109_b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PropylthiouracilPROPYLTHIOURACILEndo USA, Inc.b0c23a2c-b250-4c0d-9b2a-c1483faa2ca02024-11-22Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 006188
application number: NDA006188
ndc (product): 67253-651
PropylthiouracilPROPYLTHIOURACILAmerican Health Packagingd819e532-09ac-434a-84a6-636c4204c7aa2024-07-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 006188
application number: NDA006188

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198175propylthiouracil 50 MG Oral TabletPSNb0c23a2c-b250-4c0d-9b2a-c1483faa2ca017
198175propylthiouracil 50 MG Oral TabletSCDb0c23a2c-b250-4c0d-9b2a-c1483faa2ca017
198175PTU 50 MG Oral TabletSYb0c23a2c-b250-4c0d-9b2a-c1483faa2ca017
198175propylthiouracil 50 MG Oral TabletPSNd819e532-09ac-434a-84a6-636c4204c7aa6
198175propylthiouracil 50 MG Oral TabletSCDd819e532-09ac-434a-84a6-636c4204c7aa6
198175PTU 50 MG Oral TabletSYd819e532-09ac-434a-84a6-636c4204c7aa6

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
67253-651-1067253065110100 TABLET in 1 BOTTLE (67253-651-10) 100 tablet1947-07-280000-00-00NoNoCurrent
67253-651-11672530651111000 TABLET in 1 BOTTLE (67253-651-11) 1000 tablet1947-07-282028-07-31NoNoCurrent